Mark Davis
MD
Professor of Microbiology and Immunology
👥Biography 个人简介
Mark Davis at Stanford discovered and cloned the alpha-beta T cell receptor, one of the landmark discoveries in immunology that defined how T cells recognize antigens. His subsequent development of MHC-peptide tetramer technology for identifying and tracking antigen-specific T cells in cancer patients has been a critical tool for immune monitoring in cancer immunotherapy trials. His contributions span from fundamental TCR biology to clinical cancer immunology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Mark Davis 的研究动态
Follow Mark Davis's research updates
留下邮箱，当我们发布与 Mark Davis（Stanford University School of Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment